Company news
Angiodynamics, Inc. (NASDAQ:ANGO) news
Every Angiodynamics, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases — page 2
AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
May 6, 2024
AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
April 4, 2024
AngioDynamics Receives 510(k) Clearance for AlphaVac F18⁸⁵ System in Treatment of PE
April 4, 2024
AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
April 1, 2024
AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
March 19, 2024
AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
March 6, 2024
AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
February 15, 2024
AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
January 23, 2024
AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
January 5, 2024
AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024
December 7, 2023
AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism
December 7, 2023
AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance
October 4, 2023
AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023
September 12, 2023
AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation
August 15, 2023
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
August 3, 2023
AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference
July 31, 2023
AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors
July 24, 2023
AngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance
July 12, 2023
AngioDynamics to Report Fiscal 2023 Fourth Quarter and Full-Year Financial Results on July 12, 2023
June 20, 2023
AngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million
June 8, 2023
AngioDynamics to Present at the Needham Virtual Healthcare Conference
April 11, 2023
AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance
March 30, 2023
AngioDynamics to Report Fiscal 2023 Third Quarter Financial Results on March 30, 2023
March 13, 2023
AngioDynamics to Participate in Three Investor Conferences in March
February 28, 2023
AngioDynamics Reports Fiscal 2023 Second Quarter Financial Results; Reaffirms Guidance
January 5, 2023
AngioDynamics to Report Fiscal 2023 Second Quarter Financial Results on January 5, 2023
December 15, 2022
AngioDynamics to Present at the Piper Sandler Healthcare Conference
November 17, 2022
AngioDynamics Announces First Patient Enrolled in APEX-AV Study Assessing AlphaVac F18⁸⁵ PE System in Treatment of Pulmonary Embolism
October 31, 2022
AngioDynamics Reports Fiscal 2023 First Quarter Financial Results; Reaffirms Guidance
October 6, 2022
AngioDynamics to Report Fiscal 2023 First Quarter Financial Results on October 6, 2022
September 8, 2022
AngioDynamics to Present at the Canaccord Genuity Growth Conference
August 3, 2022
AngioDynamics Reports Fiscal Year 2022 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2023 Guidance
July 12, 2022
AngioDynamics to Report Fiscal 2022 Fourth Quarter and Full-Year Financial Results on July 12, 2022
June 15, 2022
AngioDynamics to Present at the UBS Global Healthcare Conference
May 16, 2022
AngioDynamics to Present at the BofA Securities Healthcare Conference
May 3, 2022
AngioDynamics Reports Fiscal 2022 Third Quarter Financial Results; Reaffirms Fiscal Year 2022 Guidance
April 7, 2022
AngioDynamics to Report Fiscal 2022 Third Quarter Financial Results on April 7, 2022
March 14, 2022
AngioDynamics to Present at Three Investor Conferences in March
March 8, 2022
PAVmed Appoints Shaun O’Neil as Chief Operating Officer
February 24, 2022
AngioDynamics to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 8, 2022
AngioDynamics Reports Fiscal 2022 Second Quarter Financial Results; Reaffirms Revenue Guidance; Revises Gross Margin and Adjusted EPS Guidance
January 6, 2022
AngioDynamics to Present at the Needham Virtual Growth Conference
January 3, 2022
AngioDynamics to Report Fiscal 2022 Second Quarter Financial Results on January 6, 2022
December 15, 2021
AngioDynamics Reports Fiscal 2022 First Quarter Financial Results; Updates Guidance
September 30, 2021
AngioDynamics to Report Fiscal 2022 First Quarter Financial Results on September 30, 2021
September 15, 2021
AngioDynamics to Present at the Canaccord Genuity Virtual Growth Conference
July 29, 2021
AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results
July 13, 2021
AngioDynamics Announces Details for Investor & Technology Day on July 13, 2021
July 8, 2021
AngioDynamics to Report Fiscal 2021 Fourth Quarter and Full-Year Financial Results and Host Investor & Technology Day on July 13, 2021
June 24, 2021
AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System
June 8, 2021